Predominant morphology | ||
Ulceration | 04 | 14.81 |
Vegetating | 02 | 7.41 |
Ulceration and vegetating | 06 | 22.22 |
Stenosing | 01 | 3.7 |
Non evaluated | 14 | 51.85 |
Size of the lesion (cm) | ||
≤ 0,5 | 01 | 3.7 |
0.6–2.0 | 08 | 29.63 |
2.1–5.0 | 15 | 55.56 |
≥ 5.1 | 03 | 11.11 |
UJCC/TNM Staging | ||
I | 02 | 7.41 |
II | 02 | 7.41 |
III | 09 | 33.33 |
IV | 0 | 0 |
Non evaluated | 14 | 51.85 |
Tumor Grade | ||
Well Differentiated | 06 | 22.22 |
Moderately Differentiated | 19 | 70.38 |
Poorly Differentiated | 01 | 3.7 |
Undifferentiated | 01 | 3.7 |
Invasion | ||
Present | 09 | 33.33 |
Absent | 12 | 44.45 |
Not evaluated | 06 | 22.22 |
Infiltration | ||
Anal canal wall | 01 | 3.7 |
Perianal region | 01 | 3.7 |
Perirectal fat | 01 | 3.7 |
Vagina and uterine cervix | 01 | 3.7 |
Stroma | 01 | 3.7 |
Muscle layer | 01 | 3.7 |
Perineural | 01 | 3.7 |
Vulvar | 01 | 3.7 |
Not evaluated | 01 | 3.7 |
No infiltration | 18 | 66.7 |
Lymph node involvement | ||
Yes | 07 | 25.93 |
No | 15 | 55.55 |
Not evaluated | 05 | 18.52 |
Metastasis | ||
Yes | 03 | 11.11 |
No | 19 | 70.37 |
Not evaluated | 05 | 18.52 |
Inflammatory process | ||
Yes | 05 | 18.52 |
No | 12 | 44.44 |
Not evaluated | 10 | 37.04 |
Necrosis Presence | ||
Yes | 02 | 7.41 |
No | 12 | 44.44 |
Not evaluated | 13 | 48.15 |